Evidence map›Paper›PMID 38600920›Full record

ArticleMaterials today. Bio2024

Shuhuan Li, Suwen Cao, Huihui Lu, Bingfang He, Bingbing Gao

Open access · goldAbstract read
In one paragraph

Article in Materials today. Bio, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. FromMaterials today. Bio · 2025
    Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Shuhuan LiCollege of Biotechnology and Pharmaceutical Engineering, School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing, 211816, China.
Suwen CaoCollege of Biotechnology and Pharmaceutical Engineering, School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing, 211816, China.
Huihui LuCollege of Biotechnology and Pharmaceutical Engineering, School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing, 211816, China.
Bingfang HeCollege of Biotechnology and Pharmaceutical Engineering, School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing, 211816, China.
Bingbing GaoCollege of Biotechnology and Pharmaceutical Engineering, School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing, 211816, China.
Nanjing Tech University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Joint injuries are among the leading causes of disability. Present concentrations were focused on oral drugs and surgical treatment, which brings severe and unnecessary difficulties for patients. Smart patches with high flexibility and intelligent drug control-release capacity are greatly desirable for efficient joint management. Herein, we present a novel

Indexed as

KirigamiMicroneedlesOsteoarthritisSpider fibroinTENGWounds

Identifiers

PMID38600920
PMCPMC11004194
OpenAlexW4393948663

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.